Increasing the Specificity of Neurotrophic Factors

Total Page:16

File Type:pdf, Size:1020Kb

Increasing the Specificity of Neurotrophic Factors COMMENTARY Increasing the specificity of neurotrophic factors Moses V. Chao1 The Skirball Institute of Biomolecular Medicine, New York University, New York, NY 10016 eurotrophic factors are capable of accomplishing many tasks. In N addition to regulating neural cell survival and differentiation, they can influence changes in synaptic transmission and higher order behaviors, such as aggression, addiction, depression, learning, and memory. Because many tro- phic factors use receptor tyrosine kinases as a means for initiating signaling, a major question is how tyrosine phosphorylation events that lead to canonical MAP kinase, Akt, and phospholipase C-γ activities can account for so many diverse outcomes (1). The article in PNAS by Schalm et al. (2) on protocadherins and the glial-derived neu- rotrophic factor (GDNF) provides a unique insight into this question. GDNF is an important protein that was discovered in 1993 as a potent survival factor for midbrain dopaminergic neurons (3). It has been frequently touted as a treatment for Parkinson’s disease. GDNF Fig. 1. A link between GDNF and protocadherins. A multitude of different protocadherin proteins are also exerts trophic effects on sympathetic, expressed in the nervous system. Each transmembrane protocadherin possesses six extracellular cad- sensory, parasympathetic, and enteric neu- herin domains and a short cytoplasmic segment. In the mouse, there are 14 protocadherin-α genes, 22 rons. The effects of GDNF and the related protocadherin-β genes, and 22 protocadherin-γ genes, which undergo multiple splicing events (16, family members neurturin, artemin, and 17). The GDNF family of ligands (GDNF, neurturin, artemin, and persephin) bind to individual GDNF-α persephin are mediated by RET, a trans- receptors (GFR-α), which form a complex with the RET tyrosine kinase (5). The specific protocadherin membrane receptor tyrosine kinase. GDNF proteins α4andγb7 are phosphorylated by RET after GDNF treatment, which, in turn, stabilizes RET ligands do not bind directly to RET but and delays its degradation (2). require GPI-anchored coreceptors [called GDNF receptor-α1–4] to activate the RET teracting protein of protocadherin-α4. In- junctions (8) has been backed by the ap- receptor, which efficiently increases in- terestingly, the interaction of RET with pearance of fewer and weaker synapses tracellular ERK and PI3K activities and 2+ protocadherin-α4 is specific and involves in spinal cord neurons in mice carrying Ca levels (4, 5). Many biological func- the extracellular domains of each protein, γ tions are affected by these ligand-receptor a large deletion in the protocadherin- events, including proliferation and migra- which both share similar cadherin-like gene cluster (11). motifs (Fig. 1). Moreover, the absence of multiple tion of progenitor cells, axon guidance, and γ chemoattraction (5). GDNF is also involved How are protocadherins relevant to -protocadherins results in dramatic neu- RET? Protocadherin-α was originally rodegeneration of spinal cord motor neu- in synapse formation and neuronal excit- fi fi ability in possessing the ability to modulate identi ed as a brain-speci c protein that rons (12), reminiscent of what happens postsynaptic currents in dopaminergic neu- interacted with the Fyn nonreceptor tyro- when there is a lack of trophic support. rons (6). Recently, considerable interest has sine kinase (8). It quickly became apparent Hence, protocadherins display multiple centered on the roles of GDNF to regulate that the protocadherin gene family rep- roles in the nervous system. In this re- drugs of abuse, such as cocaine and mor- resented the largest subgroup of the cad- gard, RET signaling is responsible for the phine, negatively as well as alcohol addic- herin superfamily, consisting of three survival and function of many neuron α β γ tion (7). The breadth of actions of GDNF tandemly arrayed gene clusters: , , and populations. The phosphorylation of family members begs for more mechanistic (9, 10). As a transmembrane protein with protocadherins by GDNF is therefore an insights to account for the specificity and a short cytoplasmic domain, each proto- important observation that implies an extent of RET receptor signaling and its cadherin is distinguished by six ectodo- overlap in their respective functions. ability to change synaptic plasticity. main cadherin-like repeats of 100 amino How do protocadherins and RET affect A unique set of mechanisms has now acids. Because there are nearly 70 proto- each other? One clue comes from the been provided by the finding that trans- cadherin genes that undergo a multitude finding that RET receptor levels are ex- membrane protocadherin molecules are of splicing events, a huge number of dif- quisitely sensitive to proteasomal degrada- associated with the RET receptor. Schalm ferent protocadherin proteins can be gen- tion (13, 14). Like many growth factors, et al. (2) report that GDNF causes the erated. For this reason, there has been phosphorylation of specific protocadherin enormous interest by neuroscientists in the proteins in sympathetic and motor neu- past decade in the potential roles of pro- Author contributions: M.V.C. wrote the paper. rons, two responsive populations. These tocadherins as synaptic recognition pro- The author declares no conflict of interest. interactions were uncovered by this group teins. The significance of the localization See companion article on page 13894. with the identification of RET as an in- of protocadherin proteins at synaptic 1E-mail: [email protected]. www.pnas.org/cgi/doi/10.1073/pnas.1008518107 PNAS Early Edition | 1of2 Downloaded by guest on September 23, 2021 GDNF binding results in rapid ubiquitina- loss of GDNF-RET signaling or a deficit such as discoidin domain receptor 2 and Src tion of its receptor on lysine residues. There in retrograde transport can lead to neu- family members (2). are additional layers of regulation, be- rodegeneration (14). The responsiveness Protocadherins are found in combina- cause two isoforms of RET that contain of RET receptors is therefore dependent torial expression patterns frequently asso- different lengths of cytoplasmic tails, Ret51 on receptor trafficking and turnover. ciated with synapses, and they have been and Ret9, differ in their response to Phosphorylation of protocadherins after strongly implicated as cell recognition and GDNF. Also, there is cell type specificity. GDNF treatment ensures that RET is not adhesion molecules. It is likely that their In sympathetic neurons, Ret51 is degraded immediately inactivated through degrada- effects will have an impact on the kinetics faster in sympathetic neurons than in sen- tion. The current results suggest that the and strength of signaling of other synaptic sory neurons. However, when the levels of GDNF-RET receptor exists in a large molecules. In addition to mediating neu- protocadherin-α4 are increased in sympa- complex with protocadherin proteins, ronal survival and synaptic development, thetic neurons, the levels of phosphorylated which contribute to RET receptor stability protocadherin-α members have been im- Ret51 are increased. Conversely, lowering and signaling. The existence of an array of plicated in memory and learning (15). the levels of protocadherins brings about different protocadherins and different RET Hence, the association of GDNF with a decrease in the levels of responsive RET isoforms likely generates a diversity of re- the protocadherin family of proteins may receptors (2). Hence, one way in which ceptor complexes with different compo- indeed foreshadow further insights into protocadherins exert an effect on RET is nents, thus simultaneously increasing the molecular basis of neurodegenerative to stabilize the activated receptor and the diversity and specificity of trophic factor diseases and psychiatric disorders. prevent degradation. signaling. Indeed, Schalm et al. (2) report The association of protocadherins with there are other signaling proteins that ACKNOWLEDGMENTS. The figure was composed RET has a number of implications. A de- are associated with protocadherins, includ- by Kenneth Teng, and work on neurotrophic factors in the laboratory of M.V.C. has been lay in degradation of the RET receptor ing leukocyte antigen-related receptor ty- previously supported by National Institutes of allows neurons to survive for a longer pe- rosine phosphatase and protein tyrosine Health Grants NS21072, HD23315, AG25970, riod of time in the presence of GDNF. A phosphatase-α as well as tyrosine kinases, MH086651, and MH090638. 1. Chao MV (1992) Growth factor signaling: Where is the 6. Bourque MJ, Trudeau LE (2000) GDNF enhances the 13. Pierchala BA, Milbrandt J, Johnson EM Jr. (2006) Glial specificity? Cell 68:995–997. synaptic efficacy of dopaminergic neurons in culture. cell line-derived neurotrophic factor-dependent re- 2. Schalm SS, Ballif BA, Buchanan SM, Phillips GR, Eur J Neurosci 12:3172–3180. cruitment of Ret into lipid rafts enhances signaling — Maniatis T (2010) Phosphorylation of protocadherin 7. Carnicella S, Ron D (2009) GDNF A potential target to by partitioning Ret from proteasome-dependent deg- treat addiction. Pharmacol Ther 122:9–18. proteins by the receptor tyrosine kinase Ret. Proc Natl radation. J Neurosci 26:2777–2787. 8. Kohmura N, et al. (1998) Diversity revealed by a novel Acad Sci USA 107:13894–13899. 14. Tsui CC, Pierchala BA (2010) The differential axonal family of cadherins expressed in neurons at a synaptic 3. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993) degradation
Recommended publications
  • The GDNF Family: a Role in Cancer? Graeme C
    Volume 20 Number 1 January 2018 pp. 99–117 99 www.neoplasia.com The GDNF Family: A Role in Cancer? Graeme C. Fielder*, 1, 2, Teresa Wen-Shan Yang*, 1, Mahalakshmi Razdan†, Yan Li†, Jun Lu†, Jo K. Perry‡, Peter E. Lobie§ and Dong-Xu Liu† *University of Auckland, Auckland, New Zealand; †The Centre for Biomedical and Chemical Sciences, School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand; ‡Liggins Institute, University of Auckland, Auckland, New Zealand; §Cancer Science Institute of Singapore and Department of Pharmacology, National University of Singapore, Singapore; Tsinghua Berkeley Shenzhen Institute, Tsinghua University, Shenzhen, Guangdong, P. R. China Abstract The glial cell line–derived neurotrophic factor (GDNF) family of ligands (GFLs) comprising of GDNF, neurturin, artemin, and persephin plays an important role in the development and maintenance of the central and peripheral nervous system, renal morphogenesis, and spermatogenesis. Here we review our current understanding of GFL biology, and supported by recent progress in the area, we examine their emerging role in endocrine-related and other non–hormone-dependent solid neoplasms. The ability of GFLs to elicit actions that resemble those perturbed in an oncogenic phenotype, alongside mounting evidence of GFL involvement in tumor progression, presents novel opportunities for therapeutic intervention. Neoplasia (2018) 20, 99–117 Introduction GFL Signaling The glial cell line–derived neurotrophic factor (GDNF) family of Each member of the GDNF family is expressed as a pre-pro-precursor ligands (GFLs) is comprised of four structurally related factors: protein, which is proteolytically cleaved at a putative furin-like GDNF,neurturin(NRTN),artemin(ARTN),andpersephin cleavage site (RAAR) by yet unidentified enzymes to generate an (PSPN) [1–3].
    [Show full text]
  • GDNF Family Ligands and DRG Sensory Neurons 4337
    Development 127, 4335-4344 (2000) 4335 Printed in Great Britain © The Company of Biologists Limited 2000 DEV1547 Positive and negative interactions of GDNF, NTN and ART in developing sensory neuron subpopulations, and their collaboration with neurotrophins Christel Baudet1, Åsa Mikaels1, Heiner Westphal2, Jens Johansen3, Teit E. Johansen3 and Patrik Ernfors1,* 1Laboratory of Molecular Neurobiology, Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77 Stockholm, Sweden 2Laboratory of Mammalian Genes and Development, National Institute of Health, Bethesda, MD 20892, USA 3NsGene A/S, DK-2570 Ballerup, Denmark *Author for correspondence (e-mail: [email protected]) Accepted 25 July; published on WWW 26 September 2000 SUMMARY Glial cell line-derived neurotrophic factor (GDNF), family receptors are medium sized, whereas small-caliber neurturin (NTN) and neublastin/artemin (ART) are distant nociceptive cells preferentially express a single receptor. In members of the transforming growth factor β family, contrast to brain-derived neurotrophic factor (BDNF)- and have been shown to elicit neurotrophic effects upon dependent neurons, embryonic nerve growth factor (NGF)- several classes of peripheral and central neurons. Limited dependent nociceptive neurons switch dependency to information from in vitro and expression studies has GDNF, NTN and ART postnatally. Neurons that survive in also substantiated a role for GDNF family ligands in the presence of neurotrophin 3 (NT3) or neurotrophin 4 mammalian somatosensory neuron development. Here, we (NT4), including proprioceptive afferents, Merkel end show that although dorsal root ganglion (DRG) sensory organs and D-hair afferents, are also supported by GDNF neurons express GDNF family receptors embryonically, family ligands neonatally, although at postnatal stages they they do not survive in response to their ligands.
    [Show full text]
  • Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: from Biology to Therapy
    International Journal of Molecular Sciences Review Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy 1, 1, 1,2,3, 3,4 María San Román Gil y, Javier Pozas y, Javier Molina-Cerrillo * , Joaquín Gómez , Héctor Pian 3,5, Miguel Pozas 1, Alfredo Carrato 1,2,3 , Enrique Grande 6 and Teresa Alonso-Gordoa 1,2,3 1 Medical Oncology Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain; [email protected] (M.S.R.G.); [email protected] (J.P.); [email protected] (M.P.); [email protected] (A.C.); [email protected] (T.A.-G.) 2 The Ramon y Cajal Health Research Institute (IRYCIS), CIBERONC, 28034 Madrid, Spain 3 Medicine School, Alcalá University, 28805 Madrid, Spain; [email protected] (J.G.); [email protected] (H.P.) 4 General Surgery Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain 5 Pathology Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain 6 Medical Oncology Department, MD Anderson Cancer Center, 28033 Madrid, Spain; [email protected] * Correspondence: [email protected] These authors have contributed equally to this work. y Received: 30 June 2020; Accepted: 10 July 2020; Published: 13 July 2020 Abstract: Thyroid cancer represents a heterogenous disease whose incidence has increased in the last decades. Although three main different subtypes have been described, molecular characterization is progressively being included in the diagnostic and therapeutic algorithm of these patients. In fact, thyroid cancer is a landmark in the oncological approach to solid tumors as it harbors key genetic alterations driving tumor progression that have been demonstrated to be potential actionable targets.
    [Show full text]
  • Regulation of GDNF Expression in Sertoli Cells
    157 3 REPRODUCTIONREVIEW Regulation of GDNF expression in Sertoli cells Parag A Parekh1, Thomas X Garcia2,3 and Marie-Claude Hofmann1 1Department of Endocrine Neoplasia, UT MD Anderson Cancer Center, Houston, Texas, USA, 2Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA, 3Department of Biological and Environmental Sciences, University of Houston-Clear Lake, Houston, Texas, USA Correspondence should be addressed to M-C Hofmann; Email: [email protected] Abstract Sertoli cells regulate male germ cell proliferation and differentiation and are a critical component of the spermatogonial stem cell (SSC) niche, where homeostasis is maintained by the interplay of several signaling pathways and growth factors. These factors are secreted by Sertoli cells located within the seminiferous epithelium, and by interstitial cells residing between the seminiferous tubules. Sertoli cells and peritubular myoid cells produce glial cell line-derived neurotrophic factor (GDNF), which binds to the RET/GFRA1 receptor complex at the surface of undifferentiated spermatogonia. GDNF is known for its ability to drive SSC self- renewal and proliferation of their direct cell progeny. Even though the effects of GDNF are well studied, our understanding of the regulation its expression is still limited. The purpose of this review is to discuss how GDNF expression in Sertoli cells is modulated within the niche, and how these mechanisms impact germ cell homeostasis. Reproduction (2019) 157 R95–R107 Introduction reserve stem cells (A0), coexisting with a population of renewing spermatogonia that they called A1–A4 Proper regulation of stem cell fate is critical to maintain (Clermont & Leblond 1953, Clermont & Bustos-Obregon adequate cell numbers in health and diseases.
    [Show full text]
  • Neuronal Types and Their Specification Dynamics in the Autonomic Nervous System
    From the Department of Medical Biochemistry and Biophysics Karolinska Institutet, Stockholm, Sweden NEURONAL TYPES AND THEIR SPECIFICATION DYNAMICS IN THE AUTONOMIC NERVOUS SYSTEM Alessandro Furlan Stockholm 2016 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by E-Print AB © Alessandro Furlan, 2016 ISBN 978-91-7676-419-0 On the cover: abstract illustration of sympathetic neurons extending their axons Credits: Gioele La Manno NEURONAL TYPES AND THEIR SPECIFICATION DYNAMICS IN THE AUTONOMIC NERVOUS SYSTEM THESIS FOR DOCTORAL DEGREE (Ph.D.) By Alessandro Furlan Principal Supervisor: Opponent: Prof. Patrik Ernfors Prof. Hermann Rohrer Karolinska Institutet Max Planck Institute for Brain Research Department of Medical Biochemistry and Research Group Developmental Neurobiology Biophysics Division of Molecular Neurobiology Examination Board: Prof. Jonas Muhr Co-supervisor(s): Karolinska Institutet Prof. Ola Hermansson Department of Cell and Molecular Biology Karolinska Institutet Department of Neuroscience Prof. Tomas Hökfelt Karolinska Institutet Assistant Prof. Francois Lallemend Department of Neuroscience Karolinska Institutet Division of Chemical Neurotransmission Department of Neuroscience Prof. Ted Ebedal Uppsala University Department of Neuroscience Division of Developmental Neuroscience To my parents ABSTRACT The autonomic nervous system is formed by a sympathetic and a parasympathetic division that have complementary roles in the maintenance of body homeostasis. Autonomic neurons, also known as visceral motor neurons, are tonically active and innervate virtually every organ in our body. For instance, cardiac outflow, thermoregulation and even the focusing of our eyes are just some of the plethora of physiological functions under the control of this system. Consequently, perturbation of autonomic nervous system activity can lead to a broad spectrum of disorders collectively known as dysautonomia and other diseases such as hypertension.
    [Show full text]
  • Multiple Endocrine Neoplasia Type 2: an Overview Jessica Moline, MS1, and Charis Eng, MD, Phd1,2,3,4
    GENETEST REVIEW Genetics in Medicine Multiple endocrine neoplasia type 2: An overview Jessica Moline, MS1, and Charis Eng, MD, PhD1,2,3,4 TABLE OF CONTENTS Clinical Description of MEN 2 .......................................................................755 Surveillance...................................................................................................760 Multiple endocrine neoplasia type 2A (OMIM# 171400) ....................756 Medullary thyroid carcinoma ................................................................760 Familial medullary thyroid carcinoma (OMIM# 155240).....................756 Pheochromocytoma ................................................................................760 Multiple endocrine neoplasia type 2B (OMIM# 162300) ....................756 Parathyroid adenoma or hyperplasia ...................................................761 Diagnosis and testing......................................................................................756 Hypoparathyroidism................................................................................761 Clinical diagnosis: MEN 2A........................................................................756 Agents/circumstances to avoid .................................................................761 Clinical diagnosis: FMTC ............................................................................756 Testing of relatives at risk...........................................................................761 Clinical diagnosis: MEN 2B ........................................................................756
    [Show full text]
  • Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma Is Mediated by BCL2
    Published OnlineFirst June 8, 2010; DOI: 10.1158/1535-7163.MCT-09-1077 Research Article Molecular Cancer Therapeutics Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma Is Mediated by BCL2 Jian-Zhong Tang1, Xiang-Jun Kong3, Jian Kang1, Graeme C. Fielder1, Michael Steiner1, Jo K. Perry1, Zheng-Sheng Wu4, Zhinan Yin5, Tao Zhu3, Dong-Xu Liu1, and Peter E. Lobie1,2 Abstract We herein show that Artemin (ARTN), one of the glial cell line–derived neurotrophic factor family of li- gands, promotes progression of human non–small cell lung carcinoma (NSCLC). Oncomine data indicate that expression of components of the ARTN signaling pathway (ARTN, GFRA3, and RET) is increased in neoplas- tic compared with normal lung tissues; increased expression of ARTN in NSCLC also predicted metastasis to lymph nodes and a higher grade in certain NSCLC subtypes. Forced expression of ARTN stimulated survival, anchorage-independent, and three-dimensional Matrigel growth of NSCLC cell lines. ARTN increased BCL2 expression by transcriptional upregulation, and inhibition of BCL2 abrogated the oncogenic properties of ARTN in NSCLC cells. Forced expression of ARTN also enhanced migration and invasion of NSCLC cells. Forced expression of ARTN in H1299 cells additionally resulted in larger xenograft tumors, which were high- ly proliferative, invasive, and metastatic. Concordantly, either small interfering RNA–mediated depletion or functional inhibition of endogenous ARTN with antibodies reduced oncogenicity and invasiveness of NSCLC cells. ARTN therefore mediates progression of NSCLC and may be a potential therapeutic target for NSCLC. Mol Cancer Ther; 9(6); 1697–708. ©2010 AACR. Introduction Therefore, identification and subsequent targeting of novel oncogenic pathways may provide an advantage to Lung carcinoma is currently responsible for the highest the current regimens used to treat lung carcinoma and cancer-related mortality worldwide, with overall 5-year consequently improve prognosis.
    [Show full text]
  • Expression and Regulation of GFR 3, a Glial Cell Line-Derived Neurotrophic
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 1295–1300, February 1998 Neurobiology Expression and regulation of GFRa3, a glial cell line-derived neurotrophic factor family receptor PHILIPPE NAVEILHAN*, CHRISTEL BAUDET*, ÅSA MIKAELS*, LIYA SHEN†,HEINER WESTPHAL†, AND PATRIK ERNFORS*‡ *Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, S17177 Stockholm, Sweden, and †Laboratory of Mammalian Genes and Development, National Institutes of Health, Bethesda, MD 20892 Communicated by Tomas Hokfelt, Karolinska Institute, Stockholm, Sweden, November 26, 1997 (received for review September 22, 1997) ABSTRACT We report the identification of an additional The switch from NT3 dependency is paralleled by the down- member of the glial cell line-derived neurotrophic factor regulation of the NT3 receptor, trkC (25). (GDNF) family receptor, termed GFRa3, that is homologous Recently, a family of neurotrophic factors has been discov- to the previously identified GDNF and neurturin ligand ered, including the structurally related ligands glial cell line- binding receptors GFRa1 and GFRa2. GFRa3 is 32% and 37% derived neurotrophic factor (GDNF) and neurturin (NTN) identical to GFRa1 and GFRa2, respectively. RNase protec- (26, 27). They are distant members to the transforming growth tion assays show that whereas gfra1 and gfra2 are abundant factor b family. GDNF is a potent survival factor for several in both developing and adult brain, gfra3 is exclusively populations of central neurons in culture and in vivo. GDNF expressed during development. All receptors are widely protects lesioned adult substantia nigra dopaminergic neurons present in both the developing and adult peripheral nervous from death (26, 28–30) and rescues developing and lesioned system and in peripheral organs.
    [Show full text]
  • Plasma Membrane Localization of the GFL Receptor Components: a Nexus for Receptor Crosstalk
    Cell and Tissue Research (2020) 382:57–64 https://doi.org/10.1007/s00441-020-03235-4 AT-A-GLANCE ARTICLE Plasma membrane localization of the GFL receptor components: a nexus for receptor crosstalk Christopher R. Donnelly1 & Brian A. Pierchala2 Received: 19 March 2020 /Accepted: 4 June 2020 / Published online: 7 August 2020 # The Author(s) 2020 Abstract The glial cell line-derived neurotrophic factor (GDNF) family ligands (GFLs) comprise a group of four homologous and potent growth factors that includes GDNF, neurturin (NRTN), artemin (ARTN), and persephin (PSPN). The survival, growth, and mitotic activities of the GFLs are conveyed by a single receptor tyrosine kinase, Ret. The GFLs do not bind directly to Ret in order to activate it, and instead bind with high affinity to glycerophosphatidylinositol (GPI)-anchored coreceptors called the GDNF family receptor-αs(GFRαs). Several mechanisms have recently been identified that influence the trafficking of Ret and GFRαs in and out of the plasma membrane, thereby affecting their availability for ligand binding, as well as their levels by targeting to degradative pathways. This review describes these mechanisms and their powerful effects on GFL signaling and function. We also describe the recent discovery that p75 and Ret form a signaling complex, also regulated by plasma membrane shuttling, that either enhances GFL survival signals or p75 pro-apoptotic signals, dependent on the cellular context. Keywords Ret . GFRα . Plasma membrane . Intracellular trafficking . GDNF . GFLs . TGF-β regulation Introduction receptors, as well as other classes of receptors, and the cellular context of these interactions ultimately determines the fate of In the past, illustrations detailing neurotrophic factor signaling neurons during neural development (e.g., survival, death, dif- pathways often indicated relatively simplistic interactions be- ferentiation, axon growth).
    [Show full text]
  • R&D Systems Products for Neuroscience Research
    R&D Systems Tools for Cell Biology Research™ R&D Systems Products for Neuroscience Research ON THE COVER This illustration was featured in the Cytokine Bulletin (2010, Issue 1). TLR2 IL-6 IL-6 R MOG IL-21 R TGF-β R STAT3 Dendritic TGF-β Cell STAT3 Batf, RORγt IL-23 Batf RORγt Th17 Cell IL-23 R IL-17 JunB Batf RORγt IL-17 NO Myelin TNF-α Axon MMPs Macrophages Neuron Oligodendrocyte Prolonged production of IL-17 by Th17 cells is dependent on the transcription factor Batf. Recent studies suggest that prolonged production of IL-17 by Th17 cells is dependent on the synergistic actions of the RORt and Batf-JunB transcription factors. These fi ndings may have implications for Th17-related autoimmune disorders such as multiple sclerosis. Following induction of autoimmune conditions in mice using myelin oligodendrocyte glycoprotein (MOG) immunization, diff erentiated Th17 cells secrete proinfl ammatory cytokines, and activated macrophages destroy myelin and damage oligodendrocytes. It remains to be determined whether the induction of Batf expression is dependent on STAT3 in Th17 cells, and whether an interaction between Batf and Irf4 or Ahr is required to promote the respective induction of IL-21 and IL-22. Schraml, B.U. et al. (2009) Nature 460:405. To request the most recent issue of the Cytokine Bulletin and other R&D Systems literature please visit www.RnDSystems.com/go/Request R&D Systems Tools for Cell Biology Research™ R&D Systems Cytokine Bulletin Cytokine BULLETIN 2011 | Issue 2 Adipose Tissue INSIDE s)NFLAMMATION s$ECREASEDADIPOGENESIS
    [Show full text]
  • Gdnf Family Receptors in Peripheral Target Innervation and Hormone Production
    GDNF FAMILY RECEPTORS IN PERIPHERAL TARGET INNERVATION AND HORMONE PRODUCTION Päivi Lindfors Neuroscience Center and Department of Biological and Environmental Sciences and Helsinki Graduate School in Biotechnology and Molecular Biology, Faculty of Biosciences, University of Helsinki Academic dissertation To be presented for public criticism, with the permission of the Faculty of Biosciences, University of Helsinki, in auditorium 1041 at Viikki Biocenter, on 1 September, 2006, at 12 noon. Helsinki 2006 1 Supervised by: Docent Matti Airaksinen Neuroscience Center University of Helsinki Finland Reviewed by: Docent Kirsi Sainio Institute of Biomedicine University of Helsinki Finland and Docent Juha Partanen Institute of Biotechnology University of Helsinki Finland Opponent: Professor Klaus Unsicker Institute for Anatomy and Cell Biology University of Heidelberg Germany ISBN 952-10-3309-6 (print) ISBN 952-10-3310-X (ethesis, pdf) Yliopistopaino, Helsinki 2006 2 To Mika 3 TABLE OF CONTENTS SELECTED ABBREVIATIONS ..................................................................................6 LIST OF ORIGINAL PUBLICATIONS.......................................................................7 ABSTRACT...................................................................................................................8 REVIEW OF THE LITERATURE ...............................................................................9 Introduction....................................................................................................................9
    [Show full text]
  • Neurotrophic Factors and Receptors in the Immature and Adult Spinal Cord After Mechanical Injury Or Kainic Acid
    The Journal of Neuroscience, May 15, 2001, 21(10):3457–3475 Neurotrophic Factors and Receptors in the Immature and Adult Spinal Cord after Mechanical Injury or Kainic Acid Johan Widenfalk, Karin Lundstro¨ mer, Marie Jubran, Stefan Brene´ , and Lars Olson Department of Neuroscience, Karolinska Institute, S-171 77 Stockholm, Sweden Delivery of neurotrophic factors to the injured spinal cord has mRNA increased in astrocytes of degenerating white matter. been shown to stimulate neuronal survival and regeneration. The relatively limited upregulation of neurotrophic factors in the This indicates that a lack of sufficient trophic support is one spinal cord contrasted with the response of affected nerve factor contributing to the absence of spontaneous regeneration roots, in which marked increases of NGF and GDNF mRNA in the mammalian spinal cord. Regulation of the expression of levels were observed in Schwann cells. The difference between neurotrophic factors and receptors after spinal cord injury has the ability of the PNS and CNS to provide trophic support not been studied in detail. We investigated levels of mRNA- correlates with their different abilities to regenerate. Kainic acid encoding neurotrophins, glial cell line-derived neurotrophic fac- delivery led to only weak upregulations of BDNF and CNTF tor (GDNF) family members and related receptors, ciliary neu- mRNA. Compared with several brain regions, the overall re- rotrophic factor (CNTF), and c-fos in normal and injured spinal sponse of the spinal cord tissue to kainic acid was weak. The cord. Injuries in adult rats included weight-drop, transection, relative sparseness of upregulations of endogenous neurotro- and excitotoxic kainic acid delivery; in newborn rats, partial phic factors after injury strengthens the hypothesis that lack of transection was performed.
    [Show full text]